Eloxx Pharmaceuticals, Inc. (ELOX) › Shares OutstandingEloxx Pharmaceuticals, Inc. (ELOX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2011: 77.77M2012: 94.11M2013: 2.27M2014: 13.85M2015: 18.75M2016: 4.21M2017: 27.53M2018: 35.86M2019: 40.03M2020: 40.16M2021: 2.17M2022: 2.17M2023: 3.14M2024: 3.53M2025: 4.79M4.79M2011Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY20254.79M+35.5%20243.53M+12.4%20233.14M+45.1%20222.17M+0.0%20212.17M-94.6%202040.16M+0.3%201940.03M+11.6%201835.86M+30.3%201727.53M+554.6%20164.21M-77.6%201518.75M+35.4%201413.85M+509.4%20132.27M-97.6%201294.11M+21.0%201177.77M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share